Actively Recruiting
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-04-24
2400
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Inflammatory or degenerative diseases of the brain and spinal cord, such as multiple sclerosis, may be related to problems with an individual s immune system. However, more information is needed on the ways in which the cells of the immune system interact with the central nervous system (CNS). This study will compare tests performed on both healthy volunteers and individuals who have signs or symptoms of immune-related damage to their CNS. This study will include two groups of subjects at least 12 years old. Subjects will either have symptoms of immune-related CNS damage, or will be healthy volunteers selected for comparison purposes. Study participants will visit the NIH Clinical Center on an outpatient basis for an initial evaluation visit. During the visit, patients will provide a comprehensive medical history and undergo a neurological examination, and will provide blood samples for research purposes. The healthy volunteers will be asked to schedule a return visit for a magnetic resonance imaging (MRI) procedure, and may be asked to undergo other tests requested by the study researchers on an as-needed basis. The group of patients with symptoms of immune-related CNS damage will be asked to undergo a series of tests, including the following: * MRI procedures, with a minimum of three brain MRIs and one spinal cord MRI taken approximately 4 weeks apart * A diagnostic lumbar puncture, performed on an outpatient basis * Tests of brain and vision activity * Additional blood and tissue samples Patients with symptoms of immune-related CNS damage may be offered the opportunity to participate in additional followup tests with NIH researchers.
CONDITIONS
Official Title
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with clinical symptoms or neuroimaging evidence consistent with immune-mediated CNS disorder
- At least 12 years old at enrollment
- Willing to share medical records including past MRI results
- Adults able to give informed consent or have a legal representative; minors with parental consent and child assent as appropriate
- For in-person patients: able to undergo lumbar puncture, MRI, and clinical evaluations
- Patients of any age able to provide or have surrogate consent for biological sample processing
- Healthy volunteers at least 18 years old with normal vital signs and able to give informed consent and undergo research procedures such as blood draw and lumbar puncture
You will not qualify if you...
- Significant medical conditions that make research participation impossible or risky
- For in-person patients: contraindications for MRI such as non-removable implants or devices
- Unwillingness to consent for biological sample collection or storage
- Healthy volunteers with systemic inflammatory or neurological diseases
- History of alcohol or substance abuse
- Medical contraindications for MRI or lumbar puncture
- Psychological contraindications for MRI such as claustrophobia
- Pregnancy or breastfeeding
- History of auditory disorders like hearing impairment or tinnitus
- Any contraindications to study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
A
Amir Moghadam Ahmadi, M.D.
CONTACT
B
Bibiana Bielekova, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here